Targeted intervention in nerve–cancer crosstalk enhances pancreatic cancer chemotherapy

Jiaqi Qin,Jingjie Liu,Zhaohan Wei,Xin Li,Zhaoxia Chen,Jianye Li,Wenxia Zheng,Haojie Liu,Shiyi Xu,Tuying Yong,Ben Zhao,Shanmiao Gou,Shenghong Ju,Gao-Jun Teng,Xiangliang Yang,Lu Gan
DOI: https://doi.org/10.1038/s41565-024-01803-1
IF: 38.3
2024-11-05
Nature Nanotechnology
Abstract:Nerve–cancer crosstalk has gained substantial attention owing to its impact on tumour growth, metastasis and therapy resistance. Effective therapeutic strategies targeting tumour-associated nerves within the intricate tumour microenvironment remain a major challenge in pancreatic cancer. Here we develop Escherichia coli Nissle 1917-derived outer membrane vesicles conjugated with nerve-binding peptide NP41, loaded with the tropomyosin receptor kinase (Trk) inhibitor larotrectinib (Lar@NP-OMVs) for tumour-associated nerve targeting. Lar@NP-OMVs achieve efficient nerve intervention to diminish neurite growth by disrupting the neurotrophin/Trk signalling pathway. Moreover, OMV-mediated repolarization of M2-like tumour-associated macrophages to an M1-like phenotype results in nerve injury, further accentuating Lar@NP-OMV-induced nerve intervention to inhibit nerve-triggered proliferation and migration of pancreatic cancer cells and angiogenesis. Leveraging this strategy, Lar@NP-OMVs significantly reduce nerve infiltration and neurite growth promoted by gemcitabine within the tumour microenvironment, leading to augmented chemotherapy efficacy in pancreatic cancer. This study sheds light on a potential avenue for nerve-targeted therapeutic intervention for enhancing pancreatic cancer therapy.
materials science, multidisciplinary,nanoscience & nanotechnology
What problem does this paper attempt to address?